跳至主要内容
临床试验/IRCT20231229060558N1
IRCT20231229060558N1招募中3 期

Evaluation of the efficacy of probiotics in Nonalcoholic Fatty Liver Disease treatmenth

Mashhad University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 75 years(—)
性别
All

入选标准

  • People between 20 and 75 years old with confirmed fatty liver in Persian Cohort of Mashhad

排除标准

  • Liver failure
  • Suffering from hepatitis (viral, autoimmune, metabolic, medicinal)
  • History of alcohol consumption
  • People with ALT or AST more than 5 times normal •
  • Pregnant people
  • Taking drugs that can cause hepatic steatosis, including antiarrhythmic drugs (Amiodarone) ), anti-metabolite antineoplastic drugs (methotrexate), hormonal antineoplastic drugs (tamoxifen), corticosteroids, anticonvulsant drugs, antiretroviral drugs
  • use of antihypertensive drugs, vastatins)
  • known hereditary defects (iron and copper). Storage diseases and alpha 1 antitrypsin deficiency

研究者

相似试验

Effect of probiotics in Nonalcoholic Fatty Liver | 临床试验